# Behavior Enhances Drug Reduction of Incontinence (BE-DRI)

> **NCT00090584** · NA · COMPLETED · sponsor: **Carelon Research** · enrollment: 307 (actual)

## Conditions studied

- Urinary Incontinence (UI)

## Interventions

- **DRUG:** Tolterodine
- **BEHAVIORAL:** Behavioral training

## Key facts

- **NCT ID:** NCT00090584
- **Lead sponsor:** Carelon Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2005-12
- **Final completion:** 2006-08
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2013-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00090584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00090584, "Behavior Enhances Drug Reduction of Incontinence (BE-DRI)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00090584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*